ClinicalTrials.Veeva

Menu

Diffusion Imaging in Acute Auto-immune Encephalitis

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Auto-immune Encephalitis

Treatments

Other: Analysis of every MRI at presentation of the symptoms and then over a period of 3 to 24 months if available.

Study type

Observational

Funder types

Other

Identifiers

NCT04339205
Imaging study

Details and patient eligibility

About

The aim of this non randomised retrospective study is to investigate the imaging (MRI) of auto-immune encephalitis at presentation, especially in diffusion-weighted sequences.

Indeed, few series describe the MRI aspect of auto-immune at their beginning. Recognize early MRI abnormalities seen in auto-immune encephalitis could help reduce the time to positive diagnosis and improve the therapeutic management.

Enrollment

80 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Auto-immune encephalitis proved by biological results (blood and/or CSF sample)

Exclusion criteria

  • No MRI available

Trial contacts and locations

1

Loading...

Central trial contact

Géraldine PICARD; François cotton, phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems